Read the Latest
In this blog, Doug Huynh provides an inside look at recent congressional activity surrounding H.R. 3164—the “Main Street Pharmacy Access Act,” formerly known as ECAPS. He breaks down what this progress means for pharmacists, patients, and the broader healthcare system, and why this moment represents an important step toward recognizing pharmacists as essential Part B providers.
Magaly Rodriguez de Bittner, PharmD, MS, FAPhA, FNAP, FFIP—in her first blog as APhA President—reflects on the values that continue to shape the future of pharmacy: passion, purpose, and joy.
In this blog, Douglas Huynh offers a behind-the-scenes look at how lobbying works in practice—cutting through spin, navigating political realities, and seizing legislative opportunities. Through the story of the ECAPS Act and its attempt to ride along in a reconciliation package, he shows how politics often trumps policy, even when everything seems lined up for success.
As a lobbyist, one of the many questions I get asked often is what became of a piece of legislation we supported or opposed as an organization. As is the case many times, the answer is – it’s complicated.
The first half of 2025 has demonstrated just how powerful pharmacy advocacy can be when national and state organizations work in alignment.